Back to Top
Go Back
Journal Photo for Translational Neurodegeneration
Peer reviewed only Open Access

Translational Neurodegeneration (TN)

Publisher : Springer Nature
Neurodegenerative Diseases Clinical Neurology Molecular Neuroscience
e-ISSN 2047-9158
Issue Frequency Continuously
Est. Year 2012
Mobile 4962214870
Language English
APC YES
Email customerservice@springernature.com

Journal Descriptions

Translational Neurodegeneration is a peer reviewed open access journal that focuses on bridging basic neuroscience research and clinical applications in neurodegenerative diseases. The journal emphasizes translational studies that aim to convert laboratory discoveries into therapeutic strategies for disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other related neurological conditions. It publishes original research articles, reviews, and methodological studies that investigate disease mechanisms, biomarkers, diagnostic tools, and treatment approaches. A strong focus is placed on molecular and cellular neuroscience, neuroimaging, genetics, neuroinflammation, and neuropharmacology. The journal also encourages interdisciplinary research integrating bioinformatics, systems biology, and clinical neurology to better understand disease progression and potential interventions. As an open access journal, it ensures global accessibility to scientific findings, supporting faster dissemination of knowledge across research and medical communities. Its mission is to accelerate the development of effective therapies for neurodegenerative diseases by promoting collaboration between neuroscientists, clinicians, and pharmaceutical researchers worldwide.

Translational Neurodegeneration (TN) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Neurodegenerative Diseases, Clinical Neurology, Molecular Neuroscience, Translational Medicine, Neurobiology & Pharmacology, methodological studies that investigate disease mechanisms, biomarkers, diagnostic tools, treatment approaches, placed on molecular and cellular neuroscience, neuroimaging, genetics, neuroinflammation, neuropharmacology, systems biology, and clinical neurology to better understand disease progression and potential interventions , Online , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2047-9158, Established: 2012,
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing